Active, not recruiting
Campath-1H and EPOCH to Treat Non-Hodgkin's T- and NK-Cell Lymphomas
BENdamustine at Elevated Dose for Relapsed Follicular Lymphoma in Intensification Therapy and Transplantation (BENEFIT)
Genetic Determinations for Side Effects and Response Rate for Patients Receiving Chemotherapy With Diffuse Large Cell Lymphoma
† Study has passed its completion date and status has not been verified in more than two years.